In the Know

FDA Programs to Expedite the Development and Review of Drugs and Biologics for Serious Conditions
AGG Seminars & Webinars
June 6, 2019

Join AGG attorneys for a high-level review of four FDA programs to expedite the development and review of drugs and biologics for the treatment of serious conditions: 1. Fast Track Designation 2. Breakthrough Therapy Designation 3. Accelerated Approval 4. Priority Review Designation.

Register now for this one-hour complimentary webinar with AGG Partner Alan G. Minsk and Of Counsel (former FDA, Office of Chief Counsel Attorney) Seth S. Ray as they review and discuss:

  • Overview of the similarities and differences of the four programs
  • Challenges and opportunities when using these programs
  • There will be an opportunity for Q&A following the presentation.

Credits: This webinar is pending CLE credit approval by the State Bar of Georgia.